vanilmandelic acid has been researched along with 22q11 Deletion Syndrome in 1 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
22q11 Deletion Syndrome: Condition with a variable constellation of phenotypes due to deletion polymorphisms at chromosome location 22q11. It encompasses several syndromes with overlapping abnormalities including the DIGEORGE SYNDROME, VELOCARDIOFACIAL SYNDROME, and CONOTRUNCAL AMOMALY FACE SYNDROME. In addition, variable developmental problems and schizoid features are also associated with this syndrome. (From BMC Med Genet. 2009 Feb 25;10:16) Not all deletions at 22q11 result in the 22q11deletion syndrome.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evers, LJ | 1 |
| Curfs, LM | 1 |
| Bakker, JA | 1 |
| Boot, E | 1 |
| da Silva Alves, F | 1 |
| Abeling, N | 1 |
| Bierau, J | 1 |
| Drukker, M | 1 |
| van Amelsvoort, TA | 1 |
1 other study available for vanilmandelic acid and 22q11 Deletion Syndrome
| Article | Year |
|---|---|
Serotonergic, noradrenergic and dopaminergic markers are related to cognitive function in adults with 22q11 deletion syndrome.
Topics: 22q11 Deletion Syndrome; Adult; Biomarkers; Case-Control Studies; Cognition Disorders; Dopamine; Fem | 2014 |